ATE374048T1 - Verwendung von matrixprotein für gesteuerte geweberegenerationen - Google Patents

Verwendung von matrixprotein für gesteuerte geweberegenerationen

Info

Publication number
ATE374048T1
ATE374048T1 AT02735749T AT02735749T ATE374048T1 AT E374048 T1 ATE374048 T1 AT E374048T1 AT 02735749 T AT02735749 T AT 02735749T AT 02735749 T AT02735749 T AT 02735749T AT E374048 T1 ATE374048 T1 AT E374048T1
Authority
AT
Austria
Prior art keywords
tissue
enamel matrix
contraction
substances
connective
Prior art date
Application number
AT02735749T
Other languages
English (en)
Inventor
Stale Lyngstadaas
Stina Gestrelius
Original Assignee
Biora Bioex Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biora Bioex Ab filed Critical Biora Bioex Ab
Application granted granted Critical
Publication of ATE374048T1 publication Critical patent/ATE374048T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT02735749T 2001-02-23 2002-02-21 Verwendung von matrixprotein für gesteuerte geweberegenerationen ATE374048T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100311 2001-02-23
US28631101P 2001-04-25 2001-04-25

Publications (1)

Publication Number Publication Date
ATE374048T1 true ATE374048T1 (de) 2007-10-15

Family

ID=26068974

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02735749T ATE374048T1 (de) 2001-02-23 2002-02-21 Verwendung von matrixprotein für gesteuerte geweberegenerationen

Country Status (5)

Country Link
EP (1) EP1361905B8 (de)
AT (1) ATE374048T1 (de)
CA (1) CA2438084C (de)
DE (1) DE60222633T2 (de)
WO (1) WO2002080994A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0403014D0 (sv) 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
WO2006064381A2 (en) 2004-12-10 2006-06-22 Straumann Holding Ag Protein formulation
WO2011051457A2 (en) 2009-11-02 2011-05-05 Straumann Holding Ag Purified emd protein composition
WO2011073447A1 (en) 2009-12-18 2011-06-23 Straumann Holding Ag Emd c-depleted
WO2012049324A2 (en) 2010-10-15 2012-04-19 Straumann Holding Ag New emd formulation comprising pga

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1059934B1 (de) * 1998-02-27 2002-07-24 Biora Bioex AB Matrixprotein enthaltende zusammensetzungen zur wundheilung
ES2215028T3 (es) * 1999-03-10 2004-10-01 Biora Bioex Ab Composiciones de proteinas de matrices destinadas para el injertado en tejidos no mineralizados.

Also Published As

Publication number Publication date
CA2438084C (en) 2011-02-15
DE60222633D1 (de) 2007-11-08
CA2438084A1 (en) 2002-10-17
EP1361905B8 (de) 2007-12-12
HK1058488A1 (en) 2004-05-21
EP1361905A1 (de) 2003-11-19
WO2002080994A1 (en) 2002-10-17
DE60222633T2 (de) 2008-06-19
EP1361905B1 (de) 2007-09-26

Similar Documents

Publication Publication Date Title
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
ES2107041T3 (es) Variantes de activador de plasminogeno tisular obtenidos por glicosilacion, que presentan propiedades terapeuticas.
CY1105221T1 (el) Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις
DE69902234D1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
BRPI0418157A (pt) terapêutica de tumores alogênicos
CA2280873A1 (en) The use of latency associated peptide in wound healing
EP0832100A4 (de) Neuartige metalloprotease-inhibitoren, diese enthaltende pharmazeutische zusammensetzungen und anwendungsverfahren
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE60020681D1 (de) Zusammensetzungen und verfahren zur verbesserung der integrität von angegriffenen körperpassagewegen und höhlen
Wirohadidjojo et al. Platelet-rich fibrin lysate can ameliorate dysfunction of chronically UVA-irradiated human dermal fibroblasts
SE0102147D0 (sv) New methods
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
DE60025830D1 (de) Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung
BR0214196A (pt) Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer
ATE374048T1 (de) Verwendung von matrixprotein für gesteuerte geweberegenerationen
EA200401586A1 (ru) Композиции для терапевтического использования, включающие витамин а, соль металла и инсулин либо гормон роста
DE50313329D1 (de) 1-phenyl-2-dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz
DE69920015D1 (de) Verfahren zur induktion der herstellung von wachstumsfaktoren
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
CY1106235T1 (el) Χρηση της l-καρνιτινης ως σταθepοποιητικου παραγοντα πρωτεϊνων
EP1143996A4 (de) Methode zur behandlung von chronischen herzerkrankungen
BR0308040A (pt) Composições farmacêuticas e cosméticas compreendendo plgf-1
Sajjad et al. The The Therapeutic Effects of Autologous Platelet-Rich Plasma Gel on Cutaneous Wound Healing in Rescued Horses: The Effects of Autologous Platelet-Rich Plasma Gel on skin Wound Healing in Horses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties